Subscribe


PD breaking news – Pharmacy prof to head meds regulation review

Emeritus Professor Lloyd Sansom to lead TGA review. 

The government has announced an independent review of the Therapeutic Goods Administration’s (TGA) regulation of medicines and medical devices, headed by Emeritus Professor Lloyd Sansom.

In announcing the “landmark review”, Health Minister Peter Dutton and Assistant Health Minister Fiona Nash also confirmed a review of the regulatory framework for the complementary medicines sector would occur in the second quarter of next year.

University of South Australia Division of Health Sciences School of Pharmacy and Medical Sciences Emeritus Professor Lloyd Sansom had played a major role in the development of the National Medicines Policy and was a former chair of the Pharmaceutical Benefits Advisory Committee, the Minister and Assistant Minister said in a joint release today.

Sansom would be assisted by Will Delaat and Professor John Horvath in the “landmark review” of the way in which the TGA regulated medicines and medical devices, the Minister and Assistant Minister said.

The review would look at areas of unnecessary, duplicative or ineffective regulation that could be removed or streamlined, and ways to enhance regulatory framework so the country continued to be well positioned to respond effectively to trends in the development, marketing and regulation of therapeutic goods, the government said.

Dutton said a modern regulatory framework was needed to allow Australians access to treatments in a timely manner.

A discussion paper would be released in the near future, with recommendations for prescription and OTC medicines and medical devices given by 31 Mar 2015, the government said.

For more, see Monday’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 25 Oct 14

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

19 Jan

Dispensary Corner 19 Jan 18 - IT MAKES perfect sense for the operation ...


19 Jan

PBA data released - THE Pharmacy Board of Australia has released ...


19 Jan

‘Out of pocket pain’ - THE Consumers Health Forum (CHF) has announced ...


19 Jan

Cannabis PBS listing? - VICTORIAN Health Minister Jill Hennessy has confirmed ...


19 Jan

Industrial hemp meet - THE Australian Industrial Hemp Conference is calling ...


19 Jan

S3 advertising permitted - THE Therapeutic Goods Administration has confirmed that ...


19 Jan

Codeine story ‘misleading’ - WHILE the rescheduling of products containing codeine ...


18 Jan

Travel Specials 18 Jan 18 - VIEW & Verandah Sale by Holland America ...


18 Jan

Dispensary Corner 18 Jan 18 - NEWLYWEDS from Northern Ireland have wasted no ...


18 Jan

CW float speculation - THE owners of Chemist Warehouse may be ...


18 Jan

Life-Long Learning - THE Australian Pharmacy Council has announced the ...


18 Jan

FIP Glasgow regos - REGISTRATIONS have opened for the 78th International ...


18 Jan

Vic Guild election - THE Victorian Branch of the Pharmacy Guild ...


18 Jan

Blood clot warning - A DRUG that women use as a ...


18 Jan

TGA reformats PIs - EFFECTIVE 01 Jan this year, all product ...


18 Jan

PBA competency standards - THE Pharmacy Practitioner Development Committee (PPDC) met ...


18 Jan

The eyes have it - RESEARCH conducted by the University of Queensland ...


18 Jan

Pharmacy role in National Pain Plan - PHARMACISTS have been identified as key advisors ...


18 Jan

SHPA affirms codeine move - THE Society of Hospital Pharmacists of Australia ...


17 Jan

Ibuprofen Double Strength 400 - ARROW Pharmaceuticals announces the launch of Chemists' ...



Show Pharmacy Daily items by month: